Enanta Pharmaceuticals
ENTA
ENTA
151 hedge funds and large institutions have $827M invested in Enanta Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 60 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $956M → $827M (-$129M)
23% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 60
73% less call options, than puts
Call options by funds: $897K | Put options by funds: $3.29M
Holders
151
Holding in Top 10
2
Calls
$897K
Puts
$3.29M
Top Buyers
| 1 | +$15.5M | |
| 2 | +$5.14M | |
| 3 | +$3.38M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.52M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$2.27M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$7.24M | |
| 3 | -$4.51M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.26M |
| 5 |
BlackRock
New York
|
-$2.53M |